MD Biosciences performs high throughput and medium throughput cell based assays using neural tissues derived from animals, iPS-derived stem cells, neuronal cells, cardiomyocytes, PBMCs, and neural micro-tissues that closely mimic the human brain.
There are many advantages to cell based assays, which are now gaining regulatory acceptance as part of the preclinical package for drug development. Cell based assays are cost and time effective, and are an advantageous model for high throughput screening, safety and efficacy. The results are highly reproducible and relevant to the clinic, especially when derived from human cells. All of our assays provide valuable insights on mode of action and can be used to evaluate therapeutics for diseases that are difficult to model in animals, like Alzheimer's.